{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:43:40Z","timestamp":1792673020691,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00415-026-13881-3","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T12:48:11Z","timestamp":1779540491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cerebrovascular risk factors impact on brain atrophy and DTI-ALPS decrease in neuromyelitis optica spectrum disorder"],"prefix":"10.1007","volume":"273","author":[{"given":"Martina","family":"Rubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Preziosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Margoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Storelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Valsasina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Albergoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Moiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2358-4320","authenticated-orcid":false,"given":"Maria A.","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"13881_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0214-9","volume":"6","author":"S Jarius","year":"2020","unstructured":"Jarius S, Paul F, Weinshenker BG, Levy M, Kim HJ, Wildemann B (2020) Neuromyelitis optica. Nat Rev Dis Primers 6:85","journal-title":"Nat Rev Dis Primers"},{"key":"13881_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-5-22","volume":"5","author":"DJ Graber","year":"2008","unstructured":"Graber DJ, Levy M, Kerr D, Wade WF (2008) Neuromyelitis optica pathogenesis and aquaporin 4. J Neuroinflammation 5:22","journal-title":"J Neuroinflammation"},{"key":"13881_CR3","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1007\/s00415-023-11634-0","volume":"270","author":"S Jarius","year":"2023","unstructured":"Jarius S, Aktas O, Ayzenberg I et al (2023) Update on the diagnosis and treatment of Neuromyelits Optica spectrum disorders (NMOSD)\u2013revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis. J Neurol 270:3341\u20133368","journal-title":"J Neurol"},{"key":"13881_CR4","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/13524585251325069","volume":"31","author":"F Chan","year":"2025","unstructured":"Chan F, Berhanu D, Samadzadeh S et al (2025) Smoking status and vascular risk factors as predictors of disability in AQP4-NMOSD and MOGAD. Mult Scler 31:658\u2013667","journal-title":"Mult Scler"},{"key":"13881_CR5","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1111\/ene.15924","volume":"30","author":"T Williams","year":"2023","unstructured":"Williams T, John N, Calvi A et al (2023) Cardiovascular risk factors in secondary progressive multiple sclerosis: a cross-sectional analysis from the MS-STAT2 randomized controlled trial. Eur J Neurol 30:2769\u20132780","journal-title":"Eur J Neurol"},{"key":"13881_CR6","first-page":"181","volume":"87","author":"N Kappus","year":"2016","unstructured":"Kappus N, Weinstock-Guttman B, Hagemeier J et al (2016) Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 87:181\u2013187","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13881_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.msard.2018.10.011","volume":"27","author":"L Lorefice","year":"2019","unstructured":"Lorefice L, Frau J, Coghe G et al (2019) Assessing the burden of vascular risk factors on brain atrophy in multiple sclerosis: a case- control MRI study. Mult Scler Relat Disord 27:74\u201378","journal-title":"Mult Scler Relat Disord"},{"key":"13881_CR8","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1093\/brain\/awaa255","volume":"143","author":"R Geraldes","year":"2020","unstructured":"Geraldes R, Esiri MM, Perera R et al (2020) Vascular disease and multiple sclerosis: a post-mortem study exploring their relationships. Brain 143:2998\u20133012","journal-title":"Brain"},{"key":"13881_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70214","volume":"32","author":"S Samadzadeh","year":"2025","unstructured":"Samadzadeh S, Oertel FC, Salih H et al (2025) Comorbidities are associated with unfavorable outcome in Aquaporin-4 antibody positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: exploratory study from the CROCTINO cohort. Eur J Neurol 32:e70214","journal-title":"Eur J Neurol"},{"key":"13881_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106035","volume":"179","author":"S Peng","year":"2023","unstructured":"Peng S, Liu J, Liang C, Yang L, Wang G (2023) Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders. Neurobiol Dis 179:106035","journal-title":"Neurobiol Dis"},{"key":"13881_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107557","volume":"33","author":"PS Ang","year":"2024","unstructured":"Ang PS, Zhang DM, Azizi SA, Norton de Matos SA, Brorson JR (2024) The glymphatic system and cerebral small vessel disease. J Stroke Cerebrovasc Dis 33:107557","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"13881_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2021.118257","volume":"238","author":"W Zhang","year":"2021","unstructured":"Zhang W, Zhou Y, Wang J et al (2021) Glymphatic clearance function in patients with cerebral small vessel disease. Neuroimage 238:118257","journal-title":"Neuroimage"},{"key":"13881_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/ana.26419","volume":"92","author":"L Cacciaguerra","year":"2022","unstructured":"Cacciaguerra L, Carotenuto A, Pagani E et al (2022) Magnetic resonance imaging evaluation of perivascular space abnormalities in Neuromyelitis Optica. Ann Neurol 92:173\u2013183","journal-title":"Ann Neurol"},{"key":"13881_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s11604-017-0617-z","volume":"35","author":"T Taoka","year":"2017","unstructured":"Taoka T, Masutani Y, Kawai H et al (2017) Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer\u2019s disease cases. Jpn J Radiol 35:172\u2013178","journal-title":"Jpn J Radiol"},{"key":"13881_CR15","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/hbm.24426","volume":"40","author":"X Guo","year":"2019","unstructured":"Guo X, Zhu J, Zhang N et al (2019) Altered neurovascular coupling in Neuromyelitis Optica. Hum Brain Mapp 40:976\u2013986","journal-title":"Hum Brain Mapp"},{"key":"13881_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for Neuromyelitis Optica Spectrum Disorders. Neurology 85:177\u2013189","journal-title":"Neurology"},{"key":"13881_CR17","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1007\/s00415-023-11710-5","volume":"270","author":"TM Moog","year":"2023","unstructured":"Moog TM, Smith AD, Burgess KW, McCreary M, Okuda DT (2023) High-efficacy therapies reduce clinical and radiological events more effectively than traditional treatments in Neuromyelitis Optica Spectrum Disorder. J Neurol 270:3595\u20133602","journal-title":"J Neurol"},{"key":"13881_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577790","volume":"363","author":"J Ma","year":"2022","unstructured":"Ma J, Yu H, Wang H, Zhang X, Feng K (2022) Evaluation of effect of empirical attack-preventive immunotherapies in Neuromyelitis Optica Spectrum Disorders: an update systematic review and meta -analysis. J Neuroimmunol 363:577790","journal-title":"J Neuroimmunol"},{"key":"13881_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.tcm.2019.05.003","volume":"30","author":"JM Flack","year":"2020","unstructured":"Flack JM, Adekola B (2020) Blood pressure and the new ACC\/AHA hypertension guidelines. Trends Cardiovasc Med 30:160\u2013164","journal-title":"Trends Cardiovasc Med"},{"key":"13881_CR20","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC202306200","volume":"176","author":"M Arvanitis","year":"2023","unstructured":"Arvanitis M, Lowenstein CJ (2023) Dyslipidemia. Ann Intern Med 176:ITC81\u2013ITC96","journal-title":"Ann Intern Med"},{"key":"13881_CR21","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.2337\/dci22-0034","volume":"45","author":"MJ Davies","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS et al (2022) Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 45:2753\u20132786","journal-title":"Diabetes Care"},{"key":"13881_CR22","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1001\/jama.2023.19897","volume":"330","author":"A Elmaleh-Sachs","year":"2023","unstructured":"Elmaleh-Sachs A, Schwartz JL, Bramante CT, Nicklas JM, Gudzune KA, Jay M (2023) Obesity management in adults: a review. JAMA 330:2000\u20132015","journal-title":"JAMA"},{"key":"13881_CR23","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/STROKEAHA.119.027230","volume":"51","author":"R Matsuo","year":"2020","unstructured":"Matsuo R, Ago T, Kiyuna F et al (2020) Smoking status and functional outcomes after Acute Ischemic Stroke. Stroke 51:846\u2013852","journal-title":"Stroke"},{"key":"13881_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2353","volume":"357","author":"A Topiwala","year":"2017","unstructured":"Topiwala A, Allan CL, Valkanova V et al (2017) Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study. BMJ 357:j2353","journal-title":"BMJ"},{"key":"13881_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neuroimage.2017.04.034","volume":"155","author":"S Valverde","year":"2017","unstructured":"Valverde S, Cabezas M, Roura E et al (2017) Improving automated multiple sclerosis lesion segmentation with a cascaded 3D convolutional neural network approach. Neuroimage 155:159\u2013168","journal-title":"Neuroimage"},{"issue":"Suppl 1","key":"13881_CR26","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","volume":"23","author":"SM Smith","year":"2004","unstructured":"Smith SM, Jenkinson M, Woolrich MW et al (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(Suppl 1):S208-219","journal-title":"Neuroimage"},{"key":"13881_CR27","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.neuroimage.2015.10.019","volume":"125","author":"JLR Andersson","year":"2016","unstructured":"Andersson JLR, Sotiropoulos SN (2016) An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging. Neuroimage 125:1063\u20131078","journal-title":"Neuroimage"},{"key":"13881_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0006-3495(94)80775-1","volume":"66","author":"PJ Basser","year":"1994","unstructured":"Basser PJ, Mattiello J, LeBihan D (1994) MR diffusion tensor spectroscopy and imaging. Biophys J 66:259\u2013267","journal-title":"Biophys J"},{"key":"13881_CR29","doi-asserted-by":"publisher","first-page":"6623","DOI":"10.1364\/AO.46.006623","volume":"46","author":"HS Abdul-Rahamn","year":"2007","unstructured":"Abdul-Rahamn HS, Gdeisat MA, Burton DR, Lalor MJ, Lilley F, Moore CJ (2007) Fast and robust three-dimensional best path phase unwrapping algorithm. Appl Opt 46:6623\u20136635","journal-title":"Appl Opt"},{"key":"13881_CR30","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/mrm.24765","volume":"71","author":"H Sun","year":"2014","unstructured":"Sun H, Wilman AH (2014) Background field removal using spherical mean value filtering and Tikhonov regularization. Magn Reson Med 71:1151\u20131157","journal-title":"Magn Reson Med"},{"key":"13881_CR31","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1109\/42.963816","volume":"20","author":"DC Alexander","year":"2002","unstructured":"Alexander DC, Pierpaoli C, Basser PJ, Gee JC (2002) Spatial transformations of diffusion tensor magnetic resonance images. IEEE Trans Med Imaging 20:1131\u20131139","journal-title":"IEEE Trans Med Imaging"},{"key":"13881_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/1522-2594(200007)44:1<41::AID-MRM8>3.0.CO;2-O","volume":"44","author":"PJ Basser","year":"2000","unstructured":"Basser PJ, Pajevic S (2000) Statistical artifacts in diffusion tensor MRI (DT-MRI) caused by background noise. Magn Reson Med 44:41\u201350","journal-title":"Magn Reson Med"},{"key":"13881_CR33","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200414","volume":"12","author":"P Preziosa","year":"2025","unstructured":"Preziosa P, Pagani E, Margoni M et al (2025) Glymphatic system may mediate the relation between choroid plexus and brain damage in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 12:e200414","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13881_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroimage.2016.10.009","volume":"145","author":"B De Leener","year":"2017","unstructured":"De Leener B, Levy S, Dupont SM et al (2017) SCT: Spinal Cord Toolbox, an open-source software for processing spinal cord MRI data. Neuroimage 145:24\u201343","journal-title":"Neuroimage"},{"key":"13881_CR35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.neuroimage.2009.12.121","volume":"50","author":"MA Horsfield","year":"2010","unstructured":"Horsfield MA, Sala S, Neema M et al (2010) Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in Multiple Sclerosis. Neuroimage 50:446\u2013455","journal-title":"Neuroimage"},{"key":"13881_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04366-7","volume":"23","author":"Z Zhuo","year":"2025","unstructured":"Zhuo Z, Xu X, Xu S et al (2025) Spatiotemporal subtypes of brain and spinal cord atrophy in Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis. BMC Med 23:514","journal-title":"BMC Med"},{"key":"13881_CR37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/ene.13224","volume":"24","author":"JW Hyun","year":"2017","unstructured":"Hyun JW, Park G, Kwak K et al (2017) Deep gray matter atrophy in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis. Eur J Neurol 24:437\u2013445","journal-title":"Eur J Neurol"},{"key":"13881_CR38","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s41593-018-0234-x","volume":"21","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Kisler K, Montagne A, Toga AW, Zlokovic BV (2018) The role of brain vasculature in neurodegenerative disorders. Nat Neurosci 21:1318\u20131331","journal-title":"Nat Neurosci"},{"key":"13881_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.26680","volume":"45","author":"M Kim","year":"2024","unstructured":"Kim M, Hwang I, Park JH et al (2024) Comparative analysis of glymphatic system alterations in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder using MRI indices from diffusion tensor imaging. Hum Brain Mapp 45:e26680","journal-title":"Hum Brain Mapp"},{"key":"13881_CR40","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1172\/JCI67677","volume":"123","author":"JJ Iliff","year":"2013","unstructured":"Iliff JJ, Lee H, Yu M et al (2013) Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. J Clin Invest 123:1299\u20131309","journal-title":"J Clin Invest"},{"key":"13881_CR41","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1113\/JP277635","volume":"597","author":"J Iliff","year":"2019","unstructured":"Iliff J, Simon M (2019) CrossTalk proposal: the glymphatic system supports convective exchange of cerebrospinal fluid and brain interstitial fluid that is mediated by perivascular aquaporin-4. J Physiol 597:4417\u20134419","journal-title":"J Physiol"},{"key":"13881_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07318-3","volume":"9","author":"H Mestre","year":"2018","unstructured":"Mestre H, Tithof J, Du T et al (2018) Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension. Nature Communications 9:4878","journal-title":"Nature Communications"},{"key":"13881_CR43","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S1474-4422(15)00141-6","volume":"14","author":"A Waisman","year":"2015","unstructured":"Waisman A, Liblau RS, Becher B (2015) Innate and adaptive immune responses in the CNS. Lancet Neurol 14:945\u2013955","journal-title":"Lancet Neurol"},{"key":"13881_CR44","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of Neuromyelitis Optica. Lancet Neurol 6:805\u2013815","journal-title":"Lancet Neurol"},{"key":"13881_CR45","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/glia.22319","volume":"60","author":"NN Haj-Yasein","year":"2012","unstructured":"Haj-Yasein NN, Jensen V, Ostby I et al (2012) Aquaporin-4 regulates extracellular space volume dynamics during high-frequency synaptic stimulation: a gene deletion study in mouse hippocampus. Glia 60:867\u2013874","journal-title":"Glia"},{"key":"13881_CR46","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrn3468","volume":"14","author":"MC Papadopoulos","year":"2013","unstructured":"Papadopoulos MC, Verkman AS (2013) Aquaporin water channels in the nervous system. Nat Rev Neurosci 14:265\u2013277","journal-title":"Nat Rev Neurosci"},{"key":"13881_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106418","volume":"99","author":"FF Andreao","year":"2025","unstructured":"Andreao FF, Araujo Dos Santos KD, Anselmi L et al (2025) Cognitive assessment in Neuromyelitis Optica spectrum disorders: A systematic review and meta-analysis. Mult Scler Relat Disord 99:106418","journal-title":"Mult Scler Relat Disord"},{"key":"13881_CR48","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3348\/kjr.2023.0360","volume":"24","author":"L Cacciaguerra","year":"2023","unstructured":"Cacciaguerra L, Rocca MA, Filippi M (2023) Understanding the pathophysiology and magnetic resonance imaging of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders. Korean J Radiol 24:1260\u20131283","journal-title":"Korean J Radiol"},{"key":"13881_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13451-z","volume":"272","author":"R Liu","year":"2025","unstructured":"Liu R, Kong L, Cao L et al (2025) Retinal microvascular differences between Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A cross-sectional study with diagnostic modeling. J Neurol 272:700","journal-title":"J Neurol"},{"key":"13881_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13350-3","volume":"272","author":"L Kong","year":"2025","unstructured":"Kong L, Tan X, Wang H et al (2025) Progressive retinal and microvascular neurodegeneration in Neuromyelitis Optica Spectrum Disorders: A longitudinal SS-OCT\/OCTA study. J Neurol 272:606","journal-title":"J Neurol"},{"key":"13881_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.70282","volume":"46","author":"KG Schilling","year":"2025","unstructured":"Schilling KG, Newton A, Tax C et al (2025) White matter geometry confounds diffusion tensor imaging along perivascular space (DTI-ALPS) measures. Hum Brain Mapp 46:e70282","journal-title":"Hum Brain Mapp"},{"key":"13881_CR52","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.252070","volume":"318","author":"I Mossige","year":"2026","unstructured":"Mossige I, Valnes LM, Stor\u00e5s TH, Emblem KE, Eide PK, Ringstad G (2026) Comparing glymphatic function measures: Diffusion tensor image analysis along perivascular spaces (DTI-ALPS) versus intrathecal contrast-enhanced MRI. Radiology 318:e252070","journal-title":"Radiology"},{"key":"13881_CR53","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2463\/mrms.rev.2023-0175","volume":"23","author":"T Taoka","year":"2024","unstructured":"Taoka T, Ito R, Nakamichi R, Nakane T, Kawai H, Naganawa S (2024) Diffusion tensor image analysis along the perivascular space (DTI-ALPS): Revisiting the meaning and significance of the method. Magn Reson Med Sci 23:268\u2013290","journal-title":"Magn Reson Med Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13881-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13881-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13881-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T18:02:22Z","timestamp":1781373742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13881-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["13881"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13881-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors of this manuscript declare relationships with the following companies: M. Rubin has nothing to disclose. P. Preziosa received speaker honoraria from Roche, Biogen, Novartis, Merck, Bristol Myers Squibb, Genzyme, Horizon and Sanofi; he has received research support from the Italian Ministry of Health and Fondazione Italiana Sclerosi Multipla; E. Pagani has nothing to disclose. M. Margoni reports grants and personal fees from Sanofi Genzyme, Merck Serono, Roche, Biogen, Amgen and Novartis. L. Storelli received speakers\u2019 honoraria from Biogen. E. Pagani has nothing to disclose. P. Valsasina has nothing to disclose. M. Albergoni has nothing to disclose. L. Moiola received speaker honoraria from Roche. M. Filippi is Editor-in-Chief of the Journal of Neurology, Associate Editor of Human Brain Mapping, Neurological Sciences, and Radiology; received compensation for consulting services from Almirall, Biogen, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Roche, Sanofi; speaking activities from Amgen, Bayer, Biogen, Bristol-Myers Squibb, Celgene, Chiesi Italia SpA, Eisai, Eli Lilly, Fujirebio, Genzyme, Janssen, Merck, Neopharmed Gentili, Neuraxpharm, Novartis, Novo Nordisk, Roche, Sanofi, Takeda; participation in Advisory Boards for Alexion, Biogen, Bristol-Myers Squibb, Eli Lilly, GE Healthcare Ltd, Merck, Neuraxpharm, Novartis, Roche, Sandoz, Sanofi, Takeda; scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol-Myers Squibb, Lilly, Novartis, Sanofi-Genzyme; he receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. M.A. Rocca received consulting fees from Biogen, Bristol Myers Squibb, Roche; and speaker honoraria from Alexion, Biogen, Bristol Myers Squibb, Celgene, Horizon Therapeutics Italy, Merck Serono SpA, Mitsubishi-Tanabe Pharma, Neuraxpharm, Novartis, Roche, Sandoz, and Sanofi. She receives research support from the MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. She is Associate Editor for Multiple Sclerosis and Related Disorders, and Associate Co-Editor for Europe and Africa for Multiple Sclerosis Journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This retrospective cross-sectional study involved human participants and was approved by the local ethics committee on human experimentation of IRCCS Ospedale San Raffaele (protocol no 32\u20132016). All participants provided informed consent prior to inclusion, in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"338"}}